Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-657181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65742 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09 |
filingDate |
2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106661060-B |
titleOfInvention |
Phenanthroline phosphonic acid derivatives and preparation method and application thereof |
abstract |
The present invention relates to a novel phenanthroline phosphonic acid compound and a pharmaceutically acceptable salt thereof. The compound and its pharmaceutically acceptable salt are used as collagen prolyl hydroxylase inhibitors in the preparation of prophylactic or therapeutic and collagen prolyl-4 ‑The application of hydroxylase-related disease drugs. |
priorityDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |